New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Allied Healthcare: Pharmacy Services
PGY-2 Oncology Program
Program Overview
Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. SHC is recognized by U.S. News & World Report as one of “America’s Best Hospitals,” currently on the Best Hospitals Honor Roll for the 11th consecutive year and ranked #9 as the Best Hospitals for Cancer. Stanford Cancer Institute has been a National Cancer Institute (NCI) Designated Cancer Center since 2007 and is a National Comprehensive Cancer Network (NCCN) founding member. Annually, Stanford Cancer Institute accrues more than 2000 participants in over 250 actively recruiting clinical trials to pioneer new preventative, diagnostic, and treatment strategies.
The Oncology Residency at SHC is a 12-month PGY2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center. Two applicants are accepted per year.
The program is designed to transition PGY1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming full responsibility for optimizing patient care as an oncology pharmacist.
Throughout the program, residents gain practical experience in the management of malignancies as well as cancer-related and cancer treatment-related disorders. In light of the prominent use of investigational drugs in the treatment of cancer, residents acquire the knowledge and skills necessary to practice effectively in clinical research environments. Residents also manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Other experiences include oncology administration and leadership, formulary management, teaching and precepting, and research.
Residency Contact Information
Residency Program Director: Edna Cheung, PharmD, BCOP
Phone: 650-725-5299
Mailing Address:
Stanford Health Care
Department of Pharmacy
500 Pasteur Drive, Room J010
Stanford, CA 94304
Program Mission
The mission of the PGY2 Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, develop clinical skills and knowledge in evidence-based medicine, and prepare for comprehensive practice in hematology/oncology in clinical, administrative, research, and/or academic settings. Upon completion of the residency program, the resident will:
- Provide optimal clinical care to patients with oncologic and hematologic disorders
- Function independently as an effective member of the health care team
- Educate health care professionals, students, patients, and the community about effective and safe medication use
- Establish a practice change based on a completed research project
- Develop excellent written and verbal communication skills
- Demonstrate time management and problem-solving skills
- Become a leader within the pharmacy profession
Program Structure
The PGY2 Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows goals and learning objectives are consistent with standards developed by ASHP.
Required Rotations
- Orientation and Training (1-2 weeks)
- Inpatient Hematology/Oncology (4 weeks)
- Inpatient Malignant Hematology (4-6 weeks)
- Inpatient Medical Oncology (4-6 weeks)
- Inpatient Blood and Marrow Transplantation (BMT) and Cellular Therapy (4-5 weeks)
- Outpatient Oncology/Hematology Clinics (12 weeks, divided into 2 blocks)
- Investigational Drug Services (4 weeks)
- Oncology Administration (4 weeks)
Elective Rotations
(2-3 rotations, 2-4 weeks each)
- Immunocompromised Infectious Diseases
- Palliative Care
- Informatics (Oncology Focus)
- Medical ICU
- Benign Hematology
- Outpatient Community Oncology
- Pediatric Oncology*
- Off-site Hematology/Oncology/BMT/CCT Services*
*In general, a maximum of one off-site rotation is permitted
Other elective learning experiences may be developed based on resident interest and preceptor availability.
Longitudinal Experiences
- Outpatient Oncology Clinics (16 weeks in the first half of the year, 20 weeks in the second half of the year)
- Independent research project presented at a national conference
- Residency research seminars
- Integral role in interdisciplinary patient care rounds
- Comprehensive patient care, including patient counseling and education
- Expansion of clinical pharmacist roles and initiation of new oncology pharmacy-related services
- Education to pharmacy, medical, and nursing staff as well as PGY1 pharmacy residents and students
- Forum presentations, case presentations, and journal clubs
- Active participation at the California Hematology/Oncology Pharmacy Network
- Administration projects in the hematology/oncology setting, such as monograph, policy, protocol, and guideline preparation and presentation
- Hematology/oncology medication use evaluation presented to P&T Committee
- Hematology/oncology related committee meetings
- Teaching experiences, including didactic and precepting opportunities
- Chemotherapy preparation and dispensing
- Staffing 16 hours every 3 weeks in the inpatient hematology/oncology/BMT pharmacy satellites and outpatient infusion treatment area
Compensation and Benefits
PGY-2 residents receive a competitive annual stipend of approximately $81,000 with full benefits, including an excellent health care benefits package and 10 days paid time off (PTO). In addition, PGY-2 residents receive educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.
Eligibility
- Completion of Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy
- Completion of an ASHP-accredited PGY1 residency program
- Interview at Stanford Health Care (on-site or virtual depending on the pandemic situation)
- Licensure to practice pharmacy in the state of California prior to October 1
- See Application Process for additional details
Current Residents
Cameron Rehmani, Pharm.D.
Cameron received his Bachelor of Science in Biology from Loyola Marymount University and his Doctor of Pharmacy from the University of Southern California. He completed his PGY-1 pharmacy practice residency at Stanford Health Care. His professional interests include hematologic malignancies, immunotherapy, and critical care in oncology. In his free time, Cameron enjoys exercising, playing golf, snowboarding, and spending time with friends.
Victoria Liu, Pharm.D.
Victoria received her Bachelor of Science in Molecular, Cellular and Developmental Biology and Doctor of Pharmacy degrees from the University of Washington. She then completed her PGY-1 pharmacy practice residency at Oregon Health & Science University in Portland, OR. Her professional interests include solid cancers, health information technology, and precision oncology. In her free time, Victoria enjoys completing New York Times puzzles, sipping iced coffees and exploring her new city.